Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells

Abstract Small ubiquitin-related modifier (SUMO) proteins are involved in the development of tumors. Ubiquitin-like modifier-activating enzyme 2 (UBA2) is an important member of the SUMO modification system; however, its role in clear cell renal cell carcinoma (ccRCC) is unclear. Therefore, we inves...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guoxi Zhang, Junrong Zou, Jinglin Shi, Biao Qian, Kaiyang Qiu, Quanliang Liu, Tianpeng Xie, Zhihua He, Hui Xu, Yunfeng Liao, Yuting Wu, Yanmin Li, Guancheng Xiao, Yuanhu Yuan, Rihai Xiao, Gengqing Wu, Xiaofeng Zou
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
Acceso en línea:https://doaj.org/article/ae862c9def61413fb56c973f7d4c3627
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ae862c9def61413fb56c973f7d4c3627
record_format dspace
spelling oai:doaj.org-article:ae862c9def61413fb56c973f7d4c36272021-11-14T12:06:41ZKnockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells10.1038/s41419-021-04347-72041-4889https://doaj.org/article/ae862c9def61413fb56c973f7d4c36272021-11-01T00:00:00Zhttps://doi.org/10.1038/s41419-021-04347-7https://doaj.org/toc/2041-4889Abstract Small ubiquitin-related modifier (SUMO) proteins are involved in the development of tumors. Ubiquitin-like modifier-activating enzyme 2 (UBA2) is an important member of the SUMO modification system; however, its role in clear cell renal cell carcinoma (ccRCC) is unclear. Therefore, we investigated the expression and function of UBA2 in ccRCC. Both mRNA and protein expression levels of UBA2 were found to be higher in ccRCC than in normal renal tissues and significantly related to the tumor size, Fuhrman grade, and tumor stage. UBA2 knockdown inhibited ccRCC cell growth, promoted apoptosis in vitro and in vivo, and decreased the abundance of a p53 mutant, c-Myc, and key enzymes of the SUMO modification system. Meanwhile, overexpression of UBA2 had the opposite effects. Overexpression of the p53 mutant or c-Myc alleviated the effects of UBA2 knockdown on ccRCC cell proliferation and apoptosis. In conclusion, targeting UBA2 may have a therapeutic potential against ccRCC.Guoxi ZhangJunrong ZouJinglin ShiBiao QianKaiyang QiuQuanliang LiuTianpeng XieZhihua HeHui XuYunfeng LiaoYuting WuYanmin LiGuancheng XiaoYuanhu YuanRihai XiaoGengqing WuXiaofeng ZouNature Publishing GrouparticleCytologyQH573-671ENCell Death and Disease, Vol 12, Iss 11, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Cytology
QH573-671
spellingShingle Cytology
QH573-671
Guoxi Zhang
Junrong Zou
Jinglin Shi
Biao Qian
Kaiyang Qiu
Quanliang Liu
Tianpeng Xie
Zhihua He
Hui Xu
Yunfeng Liao
Yuting Wu
Yanmin Li
Guancheng Xiao
Yuanhu Yuan
Rihai Xiao
Gengqing Wu
Xiaofeng Zou
Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells
description Abstract Small ubiquitin-related modifier (SUMO) proteins are involved in the development of tumors. Ubiquitin-like modifier-activating enzyme 2 (UBA2) is an important member of the SUMO modification system; however, its role in clear cell renal cell carcinoma (ccRCC) is unclear. Therefore, we investigated the expression and function of UBA2 in ccRCC. Both mRNA and protein expression levels of UBA2 were found to be higher in ccRCC than in normal renal tissues and significantly related to the tumor size, Fuhrman grade, and tumor stage. UBA2 knockdown inhibited ccRCC cell growth, promoted apoptosis in vitro and in vivo, and decreased the abundance of a p53 mutant, c-Myc, and key enzymes of the SUMO modification system. Meanwhile, overexpression of UBA2 had the opposite effects. Overexpression of the p53 mutant or c-Myc alleviated the effects of UBA2 knockdown on ccRCC cell proliferation and apoptosis. In conclusion, targeting UBA2 may have a therapeutic potential against ccRCC.
format article
author Guoxi Zhang
Junrong Zou
Jinglin Shi
Biao Qian
Kaiyang Qiu
Quanliang Liu
Tianpeng Xie
Zhihua He
Hui Xu
Yunfeng Liao
Yuting Wu
Yanmin Li
Guancheng Xiao
Yuanhu Yuan
Rihai Xiao
Gengqing Wu
Xiaofeng Zou
author_facet Guoxi Zhang
Junrong Zou
Jinglin Shi
Biao Qian
Kaiyang Qiu
Quanliang Liu
Tianpeng Xie
Zhihua He
Hui Xu
Yunfeng Liao
Yuting Wu
Yanmin Li
Guancheng Xiao
Yuanhu Yuan
Rihai Xiao
Gengqing Wu
Xiaofeng Zou
author_sort Guoxi Zhang
title Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells
title_short Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells
title_full Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells
title_fullStr Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells
title_full_unstemmed Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells
title_sort knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/ae862c9def61413fb56c973f7d4c3627
work_keys_str_mv AT guoxizhang knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT junrongzou knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT jinglinshi knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT biaoqian knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT kaiyangqiu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT quanliangliu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT tianpengxie knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT zhihuahe knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT huixu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT yunfengliao knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT yutingwu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT yanminli knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT guanchengxiao knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT yuanhuyuan knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT rihaixiao knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT gengqingwu knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
AT xiaofengzou knockdownofubiquitinlikemodifieractivatingenzyme2promotesapoptosisofclearcellrenalcellcarcinomacells
_version_ 1718429482675601408